The Medicare Part D drug pricing proposals in President Trump's 2019 federal budget proposal includes a policy to exclude manufacturer discounts in the coverage gap from beneficiary out-of-pocket totals, which is likely to generate significant push-back from manufacturers and patients.
The out-of-pocket proposal will lower Medicare costs by $47bn over 10 years, the budget projects. Beneficiaries progress through the three...





